Proposition - PharmXpert Academy

More documents

Recommendations

Info

The Korean Pharmaceutical Company List 363 3. R&D Figures No Section (Bio, Synthesis) The Name of Technology 1 synthesis DA-6034 Main Ingredient Flavonone dereived base 2 synthesis VMDA-3601 pCK-VEGF 3 BIO GX-12 4 synthesis DA-9102 HIV-1 DNA vaccine Use (Indications) IBD, Gastritis peripheral artery disease The Duration of Development The Stage of Development phase 2 phase 2 AIDS remedy phase 1 atopic dermatitis phase 2 5 synthesis DA-9201 asthma phase 2 6 synthesis DA-9701 fuctional dyspepsia phase 2 7 synthesis DA-1229 diabetes preclinical 8 synthesissynthesis PAM-1616 diabetes preclinical 9 synthesis DA-6650 fuctional dyspepsia preclinical 10 BIO HB-110 hepatidis B phase 1 11 BIO DA-3803 Assisted reprodcution preclinical 12 BIO DA-3021 hepatidis B,C preclinical 13 BIO DA-3031 neutropenia preclinical 14 BIO DA-3003 15 BIO DA-3051 growth failure Adult GDH Multiple screlosis preclinical preclinical 16 BIO DA-3601 brain tumor preclinical Future Plan Expected Licencing (Domestic, Oversea)
364 2007 Korea Pharmaceutical Industry Directory 4. Patent Information No The Name of Technology Application No. (Application date) Publication No. (Publication date) Priority No. Applied Country For Global Development Stage Future Plan Expected Licencing (Domestic, Oversea) 1 substance of treatment of erectile dysfunction 99-49384 353014 30 Countries including USA, EU Launching product - - 2 manufacturing process of Udenafil 00-34966 377782 30 Countries including USA, EU Launching product - - 3 composition of a hair restore 05-59110 664400 - Launching product - - 4 composition of calcitonine 98-16534 611559 - Launching product - - 5 composition of treatment of chloasma 00-35817 627530 - Launching product - -
Page 2 and 3:
2007 Korea Pharmaceutical Industry
Page 4 and 5:
2007 Korea Pharmaceutical Industry
Page 6 and 7:
27. ILYANG PHARM ·········
Page 8 and 9:
Chapter 1. Outline of The Project 2
Page 10 and 11:
Chapter 1. Outline of The Project 2
Page 12 and 13:
Chapter 2. Pharmaceutical Industry
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35: Chapter 2. Pharmaceutical Industry
Page 36 and 37: The Annex
Page 38 and 39: 316 2007 Korea Pharmaceutical Indus
Page 40 and 41: The Korean Pharmaceutical Company L
Page 72 and 73: 4. Company Map The Korean Pharmace
Page 134 and 135:
The Korean Pharmaceutical Company L
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
4. Company Map The Korean Pharmace
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
show all

Proposition - PharmXpert Academy

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?